Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Crispr Therapeutics Ag (CRSP)  
$51.17 2.38 (4.44%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 70,650,000
Market Cap: 3.62(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $38.62 - $89.12
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 89,721 159,721 184,721 409,721
Total Sell Value $6,558,882 $10,834,513 $12,456,407 $25,314,056
Total People Sold 3 3 3 3
Total Sell Transactions 10 12 13 22
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 483
  Page 10 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cagnoni Pablo J Director   –       •      –    2019-10-30 4 OE $5.59 $41,925 D/D 7,500 7,500     -
   Bolzon Bradley J Phd Director   –       •      –    2019-10-30 4 AS $51.89 $1,089,675 D/D (21,000) 13,745     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2019-09-01 4 D $46.21 $34,195 D/D (740) 165,061     -
   Ho Tony W Executive VP, Head of R&D   •       –      –    2019-08-02 4 D $52.56 $763,907 D/D (14,534) 45,835     -
   Ho Tony W Executive VP, Head of R&D   •       –      –    2019-08-01 4 OE $0.00 $0 D/D 37,500 60,369     -
   Klein Lawrence Otto Chief Business Officer   •       –      –    2019-07-11 4 AS $50.01 $421,171 D/D (8,421) 20,000     -
   Klein Lawrence Otto Chief Business Officer   •       –      –    2019-07-11 4 OE $5.86 $49,347 D/D 8,421 28,421     -
   Klein Lawrence Otto Chief Business Officer   •       –      –    2019-07-10 4 AS $50.02 $579,182 D/D (11,579) 20,000     -
   Klein Lawrence Otto Chief Business Officer   •       –      –    2019-07-10 4 OE $5.86 $67,853 D/D 11,579 31,579     -
   Novak Rodger President   •       •      –    2019-07-10 4 AS $50.00 $2,500,065 D/D (50,000) 848,007     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2019-06-17 4 AS $46.00 $920,000 D/D (20,000) 165,801     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2019-06-17 4 OE $1.81 $36,200 D/D 20,000 185,801     -
   Novak Rodger President   •       •      –    2019-06-10 4 AS $45.00 $2,250,000 D/D (50,000) 898,007     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2019-06-01 4 D $35.57 $26,357 D/D (741) 165,801     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2019-04-29 4 AS $42.03 $840,600 D/D (20,000) 166,542     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2019-04-29 4 OE $1.81 $36,200 D/D 20,000 186,542     -
   Ho Tony W See Remarks   •       –      –    2019-03-05 4 A $40.87 $408,700 D/D 10,000 32,869     -
   Novak Rodger President   •       •      –    2019-03-04 4 AS $40.24 $3,095,240 D/D (76,527) 948,007     -
   Novak Rodger President   •       •      –    2019-03-01 4 AS $40.01 $347,796 D/D (8,693) 1,024,534     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2019-03-01 4 D $39.97 $29,898 D/D (748) 166,542     -
   Novak Rodger President   •       •      –    2019-02-25 4 AS $40.00 $591,233 D/D (14,780) 1,033,227     -
   Novak Rodger President   •       •      –    2019-01-09 4 AS $35.01 $2,894,977 D/D (82,690) 1,048,007     -
   Novak Rodger President   •       •      –    2019-01-08 4 AS $35.09 $607,408 D/D (17,310) 1,130,697     -
   Klein Lawrence Otto Chief Business Officer   •       –      –    2019-01-02 4 A $29.87 $597,400 D/D 20,000 20,000     -
   Vertex Pharmaceuticals Inc / Ma 10% Owner   –       –       •   2018-12-27 4 B $24.95 $685,116 D/D 27,461 5,380,940 2.45     -
  483 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us